SE9802550D0 - Quinoline derivatives - Google Patents
Quinoline derivativesInfo
- Publication number
- SE9802550D0 SE9802550D0 SE9802550A SE9802550A SE9802550D0 SE 9802550 D0 SE9802550 D0 SE 9802550D0 SE 9802550 A SE9802550 A SE 9802550A SE 9802550 A SE9802550 A SE 9802550A SE 9802550 D0 SE9802550 D0 SE 9802550D0
- Authority
- SE
- Sweden
- Prior art keywords
- fluoro
- hydrogen
- iso
- formula
- prs
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/36—Sulfur atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Obesity (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Priority Applications (31)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9802550A SE9802550D0 (sv) | 1998-07-15 | 1998-07-15 | Quinoline derivatives |
TR2001/00086T TR200100086T2 (tr) | 1998-07-15 | 1999-07-14 | Kinolin türevleri. |
EP99935261A EP1097139B1 (en) | 1998-07-15 | 1999-07-14 | Quinoline derivatives |
IDW20010360A ID27547A (id) | 1998-07-15 | 1999-07-14 | Turunan kuinolin |
PL345389A PL200147B1 (pl) | 1998-07-15 | 1999-07-14 | Związki pochodne chinoliny, zawierające je kompozycje farmaceutyczne, sposób ich wytwarzania i ich zastosowanie |
BRPI9912104-2A BR9912104B1 (pt) | 1998-07-15 | 1999-07-14 | compostos derivados de quinolina, composições farmacêuticas, e, processo para a manufatura de um composto. |
AT99935261T ATE229005T1 (de) | 1998-07-15 | 1999-07-14 | Chinolinderivate |
CN99808597A CN1114597C (zh) | 1998-07-15 | 1999-07-14 | 喹啉衍生物 |
AU50775/99A AU745915B2 (en) | 1998-07-15 | 1999-07-14 | Quinoline derivatives |
OA1200100012A OA11580A (en) | 1998-07-15 | 1999-07-14 | Quinoline derivatives. |
ES99935261T ES2187176T3 (es) | 1998-07-15 | 1999-07-14 | Derivados de quinolina. |
PT99935261T PT1097139E (pt) | 1998-07-15 | 1999-07-14 | Derivados da quinolina |
APAP/P/2001/002040A AP1425A (en) | 1998-07-15 | 1999-07-14 | Quinoline derivatives. |
RU2001104344/04A RU2213734C2 (ru) | 1998-07-15 | 1999-07-14 | Производные хинолина, способ их получения (варианты), фармацевтическая композиция и способ лечения с их использованием |
KR1020007014281A KR100551611B1 (ko) | 1998-07-15 | 1999-07-14 | 퀴놀린 유도체 |
UA2000127137A UA70944C2 (uk) | 1998-07-15 | 1999-07-14 | Похідні хіноліну, спосіб їх одержання, фармацевтична композиція та лікарський засіб на їх основі |
DE69904333T DE69904333T2 (de) | 1998-07-15 | 1999-07-14 | Chinolinderivate |
JP2000560099A JP4082865B2 (ja) | 1998-07-15 | 1999-07-14 | キノリン誘導体 |
CA002334718A CA2334718C (en) | 1998-07-15 | 1999-07-14 | Quinoline derivatives |
NZ508924A NZ508924A (en) | 1998-07-15 | 1999-07-14 | N-phenyl-1,2-dihydro-4-substituted-5-sulfursubstituted-1-alkyl-2-oxo-quinoline-3-carboxamide derivatives, and pharmaceuticals thereof |
DK99935261T DK1097139T3 (da) | 1998-07-15 | 1999-07-14 | Quinolinderivater |
YU1401A YU1401A (sh) | 1998-07-15 | 1999-07-14 | Derivati hinolina |
HU0103634A HUP0103634A3 (en) | 1998-07-15 | 1999-07-14 | Quinoline derivatives |
EEP200100007A EE04276B1 (et) | 1998-07-15 | 1999-07-14 | Kinoliini derivaadid, nende valmistamine ja kasutamine ravimina ning neid sisaldavad farmatseutilised kompositsioonid |
IL14000999A IL140009A0 (en) | 1998-07-15 | 1999-07-14 | Quinoline derivatives |
PCT/SE1999/001271 WO2000003992A1 (en) | 1998-07-15 | 1999-07-14 | Quinoline derivatives |
IS5753A IS2187B (is) | 1998-07-15 | 2000-12-05 | Quinoline afleiður |
ZA200007493A ZA200007493B (en) | 1998-07-15 | 2000-12-14 | Quinoline derivatives. |
HR20010038A HRP20010038A2 (en) | 1998-07-15 | 2001-01-12 | Quinoline derivatives |
NO20010210A NO317545B1 (no) | 1998-07-15 | 2001-01-12 | Kinolinderivater |
HK01104767A HK1035716A1 (en) | 1998-07-15 | 2001-07-10 | Quinoline derivatives |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9802550A SE9802550D0 (sv) | 1998-07-15 | 1998-07-15 | Quinoline derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
SE9802550D0 true SE9802550D0 (sv) | 1998-07-15 |
Family
ID=20412094
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9802550A SE9802550D0 (sv) | 1998-07-15 | 1998-07-15 | Quinoline derivatives |
Country Status (31)
Country | Link |
---|---|
EP (1) | EP1097139B1 (et) |
JP (1) | JP4082865B2 (et) |
KR (1) | KR100551611B1 (et) |
CN (1) | CN1114597C (et) |
AP (1) | AP1425A (et) |
AT (1) | ATE229005T1 (et) |
AU (1) | AU745915B2 (et) |
BR (1) | BR9912104B1 (et) |
CA (1) | CA2334718C (et) |
DE (1) | DE69904333T2 (et) |
DK (1) | DK1097139T3 (et) |
EE (1) | EE04276B1 (et) |
ES (1) | ES2187176T3 (et) |
HK (1) | HK1035716A1 (et) |
HR (1) | HRP20010038A2 (et) |
HU (1) | HUP0103634A3 (et) |
ID (1) | ID27547A (et) |
IL (1) | IL140009A0 (et) |
IS (1) | IS2187B (et) |
NO (1) | NO317545B1 (et) |
NZ (1) | NZ508924A (et) |
OA (1) | OA11580A (et) |
PL (1) | PL200147B1 (et) |
PT (1) | PT1097139E (et) |
RU (1) | RU2213734C2 (et) |
SE (1) | SE9802550D0 (et) |
TR (1) | TR200100086T2 (et) |
UA (1) | UA70944C2 (et) |
WO (1) | WO2000003992A1 (et) |
YU (1) | YU1401A (et) |
ZA (1) | ZA200007493B (et) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE0002320D0 (sv) * | 1999-10-25 | 2000-06-21 | Active Biotech Ab | Malignant tumors |
DE60138635D1 (de) | 2000-10-12 | 2009-06-18 | Merck & Co Inc | Aza- und polyaza naphthalenyl karboxamide als inhibitoren der hiv-integrase |
DE60128936T2 (de) | 2000-10-12 | 2008-04-10 | Merck & Co, Inc. | Aza- und polyaza-naphthalenylcarbonsäureamide als hiv-integrase-hemmer |
CA2478310A1 (en) | 2002-03-15 | 2003-09-25 | Merck & Co., Inc. | N-(substituted benzyl)-8-hydroxy-1,6-naphthyridine-7-carboxamides useful as hiv integrase inhibitors |
SE0201778D0 (sv) * | 2002-06-12 | 2002-06-12 | Active Biotech Ab | Process for the manufacture of quinoline derivatives |
SE0400235D0 (sv) | 2004-02-06 | 2004-02-06 | Active Biotech Ab | New composition containing quinoline compounds |
US8314124B2 (en) | 2004-02-06 | 2012-11-20 | Active Biotech Ab | Crystalline salts of quinoline compounds and methods for preparing them |
SE0401578D0 (sv) * | 2004-06-18 | 2004-06-18 | Active Biotech Ab | Novel compounds |
EP1937642B1 (en) | 2005-10-19 | 2014-09-10 | Teva Pharmaceutical Industries Ltd | Crystals of laquinimod sodium, and process for the manufacture thereof |
KR101495327B1 (ko) | 2006-06-12 | 2015-02-24 | 테바 파마슈티컬 인더스트리즈 리미티드 | 안정한 라퀴니모드 제제 |
ES2445451T3 (es) | 2007-12-20 | 2014-03-03 | Teva Pharmaceutical Industries, Ltd. | Preparaciones estables de laquinimod |
AU2009288108B2 (en) | 2008-09-03 | 2013-10-17 | Teva Pharmaceutical Industries, Ltd. | 2-oxo-1,2-dihydro-quinoline modulators of immune function |
BR112012002124A2 (pt) | 2009-07-30 | 2015-09-15 | Teva Pharma | tratamento da doença de crohn com laquinimode. |
AU2010282948C1 (en) | 2009-08-10 | 2017-03-02 | Active Biotech, Ab | Treatment of BDNF-related disorders using laquinimod |
JP5819328B2 (ja) | 2010-03-03 | 2015-11-24 | テバ ファーマシューティカル インダストリーズ リミティド | ラキニモドとメトトレキセートとの組合せによる関節リウマチの治療 |
EP2542078B1 (en) | 2010-03-03 | 2015-10-07 | Teva Pharmaceutical Industries Ltd. | Treatment of lupus nephritis using laquinimod |
KR20130092558A (ko) | 2010-07-09 | 2013-08-20 | 테바 파마슈티컬 인더스트리즈 리미티드 | 중수소화된 n-에틸-n-페닐-1,2-다이하이드로-4-하이드록시-5-클로로-1-메틸-2-옥소퀴놀린-3-카복스아마이드, 그의 염 및 용도 |
CA2813711A1 (en) | 2010-10-14 | 2012-04-19 | Immunahr Ab | 1,2-dihydro-4-hydroxy-2-oxo-quinoline-3-carboxanilides as ahr activators. |
AU2012322706A1 (en) | 2011-10-12 | 2014-05-22 | Teva Pharmaceutical Industries Ltd. | Treatment of multiple sclerosis with combination of laquinimod and fingolimod |
CN106063787A (zh) | 2012-02-03 | 2016-11-02 | 泰华制药工业有限公司 | 拉喹莫德用于治疗一线抗TNFα疗法失败的克罗恩氏病患者的用途 |
AR090073A1 (es) | 2012-02-16 | 2014-10-15 | Teva Pharma | N-etil-n-fenil-1,2-dihidro-4,5-di-hidroxi-1-metil-2-oxo-3-quinolinacarboxamida, su preparacion y usos |
TW201350467A (zh) | 2012-05-08 | 2013-12-16 | Teva Pharma | N-乙基-4-羥基-1-甲基-5-(甲基(2,3,4,5,6-五羥基己基)胺基)-2-側氧-n-苯基-1,2-二氫喹啉-3-甲醯胺 |
TW201400117A (zh) | 2012-06-05 | 2014-01-01 | Teva Pharma | 使用拉喹莫德治療眼發炎疾病 |
TW201410244A (zh) | 2012-08-13 | 2014-03-16 | Teva Pharma | 用於治療gaba媒介之疾病之拉喹莫德(laquinimod) |
EP2916915A4 (en) | 2012-11-07 | 2016-06-22 | Teva Pharma | LAQUINIMOD AMINE SALTS |
KR20150143499A (ko) | 2013-03-14 | 2015-12-23 | 테바 파마슈티컬 인더스트리즈 리미티드 | 라퀴니모드 나트륨의 결정 및 이의 개선된 제조방법 |
KR20170005434A (ko) | 2014-04-29 | 2017-01-13 | 테바 파마슈티컬 인더스트리즈 리미티드 | 높은 장애 상태를 갖는 재발-완화형 다발성 경화증(rrms) 환자 치료용 라퀴니모드 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE52670B1 (en) * | 1981-03-03 | 1988-01-20 | Leo Ab | Heterocyclic carboxamides,compositions containing such compounds,and processes for their preparation |
GB9108547D0 (en) * | 1991-04-22 | 1991-06-05 | Fujisawa Pharmaceutical Co | Quinoline derivatives |
SE469368B (sv) * | 1991-10-09 | 1993-06-28 | Kabi Pharmacia Ab | Ny anvaendning av linomide foer tillverkning av laekemedel foer behandling av multiple sclerosis (ms) |
CN1063686A (zh) * | 1992-03-12 | 1992-08-19 | 华西医科大学药物研究所 | 用活性酯法合成维司力农 |
SE9201076L (sv) * | 1992-04-06 | 1993-10-07 | Shimon Slavin | Användningen av gamla läkemedel för behandling av diabetes |
JPH07224040A (ja) * | 1994-02-07 | 1995-08-22 | Fujisawa Pharmaceut Co Ltd | キノリン誘導体 |
GB9404378D0 (en) * | 1994-03-07 | 1994-04-20 | Fujisawa Pharmaceutical Co | Quinoline derivatives |
SE9400810D0 (sv) * | 1994-03-10 | 1994-03-10 | Pharmacia Ab | New use of Quinoline-3-carboxamide compounds |
SE9400809D0 (sv) * | 1994-03-10 | 1994-03-10 | Pharmacia Ab | New use of quinoline-3-carboxamide compounds |
GB2290786A (en) * | 1994-06-30 | 1996-01-10 | Fujisawa Pharmaceutical Co | Quinoline derivatives |
-
1998
- 1998-07-15 SE SE9802550A patent/SE9802550D0/xx unknown
-
1999
- 1999-07-14 ID IDW20010360A patent/ID27547A/id unknown
- 1999-07-14 AU AU50775/99A patent/AU745915B2/en not_active Ceased
- 1999-07-14 AP APAP/P/2001/002040A patent/AP1425A/en active
- 1999-07-14 RU RU2001104344/04A patent/RU2213734C2/ru not_active IP Right Cessation
- 1999-07-14 PL PL345389A patent/PL200147B1/pl unknown
- 1999-07-14 ES ES99935261T patent/ES2187176T3/es not_active Expired - Lifetime
- 1999-07-14 NZ NZ508924A patent/NZ508924A/xx not_active IP Right Cessation
- 1999-07-14 EP EP99935261A patent/EP1097139B1/en not_active Expired - Lifetime
- 1999-07-14 KR KR1020007014281A patent/KR100551611B1/ko not_active IP Right Cessation
- 1999-07-14 EE EEP200100007A patent/EE04276B1/et not_active IP Right Cessation
- 1999-07-14 PT PT99935261T patent/PT1097139E/pt unknown
- 1999-07-14 TR TR2001/00086T patent/TR200100086T2/xx unknown
- 1999-07-14 IL IL14000999A patent/IL140009A0/xx not_active IP Right Cessation
- 1999-07-14 OA OA1200100012A patent/OA11580A/en unknown
- 1999-07-14 YU YU1401A patent/YU1401A/sh unknown
- 1999-07-14 CA CA002334718A patent/CA2334718C/en not_active Expired - Fee Related
- 1999-07-14 WO PCT/SE1999/001271 patent/WO2000003992A1/en active IP Right Grant
- 1999-07-14 AT AT99935261T patent/ATE229005T1/de not_active IP Right Cessation
- 1999-07-14 DE DE69904333T patent/DE69904333T2/de not_active Expired - Lifetime
- 1999-07-14 DK DK99935261T patent/DK1097139T3/da active
- 1999-07-14 BR BRPI9912104-2A patent/BR9912104B1/pt not_active IP Right Cessation
- 1999-07-14 CN CN99808597A patent/CN1114597C/zh not_active Expired - Fee Related
- 1999-07-14 HU HU0103634A patent/HUP0103634A3/hu unknown
- 1999-07-14 JP JP2000560099A patent/JP4082865B2/ja not_active Expired - Fee Related
- 1999-07-14 UA UA2000127137A patent/UA70944C2/uk unknown
-
2000
- 2000-12-05 IS IS5753A patent/IS2187B/is unknown
- 2000-12-14 ZA ZA200007493A patent/ZA200007493B/en unknown
-
2001
- 2001-01-12 HR HR20010038A patent/HRP20010038A2/hr not_active Application Discontinuation
- 2001-01-12 NO NO20010210A patent/NO317545B1/no unknown
- 2001-07-10 HK HK01104767A patent/HK1035716A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE9802550D0 (sv) | Quinoline derivatives | |
SE9802549D0 (sv) | Quinoline derivatives | |
SE9801474D0 (sv) | Quinoline Derivatives | |
FI932229A (fi) | Azabicykliska bryggderivat | |
DE69410092D1 (en) | Phenyl heterocyclen als cyclooxygenase-2 inhibitoren | |
IS2750B (is) | Leiðarafesting | |
ES2167720T3 (es) | Compuestos de 1-fenilpirazol y aplicaciones medicinales de los mismos. | |
KR930016421A (ko) | 퀴놀론- 및 나프티리돈-카르복실산 유도체 | |
ATE28872T1 (de) | Neue imidazol-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate. | |
ATE109466T1 (de) | Neue derivate des aminopiperidins, aminopyrrolidins und des aminoperhydroazepins, verfahren zur herstellung und diese enthaltende arzneimittel. | |
DE69732571D1 (de) | Beta-sulfonyl-hydroxamsäuren als matrix-metalloproteinaseinhibitoren | |
CA2221114A1 (en) | Atherosclerosis treatment | |
EE200100513A (et) | Rakkude adhesiooni inhibeerivad põletikuvastased ja immunosupressiivsed ühendid | |
DE69028605T2 (de) | Aminocarbonylcarbamate verwandt mit Physostigmin, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel | |
AU6427800A (en) | Fungicidal combinations | |
DK0556813T3 (da) | Amfotere tricykliske forbindelser som antihistaminske og antiallergiske midler | |
YU61096A (sh) | Novi intermedijari, njihova primena u sintezi n,n'-premoštenih bisindolilmaleimida i farmaceutske formulacije | |
DE3887102T2 (de) | Substituierte Derivate von 20,21-Dinoreburnamenin, Verfahren zur Herstellung und so hergestellte Zwischenprodukte, ihre Verwendung als Arzneimittel und diese enthaltende pharmazeutische Zusammenstellungen. | |
EP1632228A4 (en) | MEDICINAL COMPOSITION CONTAINING TRIAZOLE COMPOUND | |
TNSN08233A1 (en) | Bicyclic cinnamide compound | |
FI931938A0 (fi) | Mellanprodukter vid framstaellning av 4,5-difluorantranilinsyra | |
ATE30675T1 (de) | Benzobicyclononanamin-derivate mit antikonvulsiven eigenschaften. | |
KR970001360A (ko) | 피리딘을 함유한 티에노피리미돈 유도체 | |
KR970001357A (ko) | 접합고리 피리딘을 함유한 벤즈이미다졸 유도체 |